National Bank of Canada’s Pfizer PFE Stock Holding History

National Bank of Canada’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-29,495	Closed	-$71.5M	–	3133
2025 Q2	$71.5M	Sell	29,495 -11,010	-27%	-$257K	0.07%	232
2025 Q1	$103M	Sell	40,505 -27,525	-40%	-$720K	0.11%	183
2024 Q4	$180M	Buy	68,030 +30,155	+80%	+$818K	0.19%	104
2024 Q3	$110M	Sell	37,875 -37,796	-50%	-$1.1M	0.13%	156
2024 Q2	$214M	Buy	75,671 +45,846	+154%	+$1.26M	0.29%	59
2024 Q1	$83.5M	Sell	29,825 -3,387	-10%	-$94K	0.13%	145
2023 Q4	$98.7M	Sell	33,212 -46,788	-58%	-$1.41M	0.16%	134
2023 Q3	$272M	Buy	+80,000	New	+$2.83M	0.41%	52

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

National Bank of Canada's PFE Position: Q1 2026 in Review

National Bank of Canada increased its Pfizer (PFE) stake by 4.8% in Q1 2026, buying an estimated $6.24M and bringing the position to 5,136,267 shares worth $144M. The position accounts for 0.13% of the portfolio, ranked #139.

National Bank of Canada first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $453M in Q3 2023. 2,946 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

National Bank of Canada held 5,136,267 shares of Pfizer worth $144M as of Q1 2026.
National Bank of Canada bought 234,500 Pfizer shares in Q1 2026, an estimated $6.24M.
Pfizer made up 0.13% of National Bank of Canada's portfolio in Q1 2026, its #139 holding.
National Bank of Canada first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
National Bank of Canada's Pfizer position peaked at $453M in Q3 2023.
2,946 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.